Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M124Revenue $M16.1Net Margin (%)-741.0Altman Z-Score-51.2
Enterprise Value $M125EPS $-0.7Operating Margin %-723.9Piotroski F-Score1
P/E(ttm)--Beneish M-Score-8.4Pre-tax Margin (%)-749.3Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %-59.2Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %-39.0Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-136.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-802.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M281ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-04-29Sell10,000$0.52-15.38view
BIANCO JAMES APresident and CEO 2016-03-28Sell10,000$0.49-10.2view
BIANCO JAMES APresident and CEO 2016-03-21Sell318,169$0.55-20view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell10,000$0.59-25.42view
BIANCO JAMES APresident and CEO 2016-02-26Sell10,000$0.63-30.16view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell15,000$0.63-30.16view
BIANCO JAMES APresident and CEO 2016-02-16Sell100,000$0.424.76view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-61.74view
BIANCO JAMES APresident and CEO 2016-01-29Sell10,000$1.2-63.33view
SINGER JACK WEVP, Chief Scientific Officer 2016-01-29Sell15,000$1.18-62.71view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

More From Other Websites
CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 29 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Apr 28 2016
Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant... Apr 20 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Apr 18 2016
CTI BioPharma Announces Presentations at the American Association of Cancer Research Annual Meeting Apr 13 2016
SHAREHOLDER NOTICE: Rosen Law Firm Reminds CTI BioPharma Corp. Investors of Important April 11, 2016... Apr 08 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CTI... Apr 08 2016
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... Apr 08 2016
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CTI... Apr 08 2016
UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of CTI BioPharma Corp. of Class... Apr 07 2016
April 11 Deadline Alert: GPM Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class... Apr 06 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against CTI BioPharma... Apr 06 2016
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... Apr 05 2016
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against CTI... Apr 05 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CTI BioPharma Corp. of Class Action... Apr 04 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 31 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CTI BioPharma Corp. of Class... Mar 31 2016
April 11 Deadline Alert: Law Offices of Howard G. Smith Reminds CTI BioPharma Corp. Investors of... Mar 31 2016
INVESTOR NOTICE: Lundin Law PC Announces Investigation of CTI BioPharma Corp. and Encourages... Mar 30 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CTI... Mar 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)